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Pancreatic cancer is one of the most deadly
forms of cancer. Although it is the fourth lead-
ing cause of cancer deaths in the United States,
it accounts for only 2% of all newly diagnosed
cancers each year. Five-year survival rates for
patients diagnosed with pancreatic cancer in
the United States average only 4.4%
(American Cancer Society 2005). In develop-
ing countries, pancreatic cancer appears to be
extremely rare. Studies in Egypt, Algeria, and
Iraq suggest a low incidence of the disease in
the Middle East (Al-Bahrani et al. 1982;
Mokhtar 1991; Parkin 1986; Parkin et al.
1997; Sherif and Ibrahim 1987). Risk factors
for this disease have generally been grouped
into four categories: a) cigarette smoking (Doll
et al. 1994; Howe et al. 1991); b) chronic pan-
creatitis (largely from alcohol consumption)
(Lowenfels et al. 1993) and genetic predisposi-
tion (Brand and Lynch 2000; Flanders and
Foulkes 1996; Goggins et al. 1996; Lowenfels
et al. 1997); c) diabetes mellitus and macro- or
micronutrients (Bueno de Mesquita et al.
1992; Everhart and Wright 1995); and
d) occupational and environmental contami-
nation from exposure to pesticides and fertiliz-
ers (Anderson et al. 1996; Fontham and
Correa 1989; Hoppin et al. 2000), manufac-
turing paints and pigments (Norell et al. 1986;
Raymond and Bouchardy 1990; Sheffet et al.
1982), metalworking (Mallin et al. 1986;
Maruchi et al. 1979; Park and Mirer 1996;
Rotimi et al. 1993; Silverstein et al. 1988;
Sparks and Wegman 1980), and soldering (Ji
et al. 1999).
The incidence of pancreatic cancer in
Egypt has been previously studied with
particular attention to Dakahlia Province
(Soliman et al. 2002). This primarily rural
province is the largest of all the provinces in
the East Nile Delta region. The population in
this region exhibits an unusually high rate of
early-onset pancreatic cancer. Although most
cases in the United States occur in patients
older than 65 years of age (Lowenfels and
Maisonneuve 1999), the incidence rates for
patients younger than 65 years in the East
Nile Delta region were more than twice as
high as those observed in Americans in the
same age group and signiﬁcantly higher than
those seen in other parts of Egypt (Soliman
et al. 2002). The reason for the incidence of
early-onset pancreatic cancer in the East Nile
Delta region is unclear. There is currently no
good evidence that the ﬁrst three risk factors
named above would preferentially affect resi-
dents of the East Nile Delta region relative to
the rest of Egypt. It is, however, well docu-
mented that this region has one of the highest
levels of pollution in Egypt.
Nile River water is seriously contaminated
with heavy metals, pesticides, and hydro-
carbons as a result of increasing discharge of
untreated industrial wastes and agricultural
irrigation wastewater (Badawy et al. 1995).
Several reports on Dakahlia Province show
high levels of heavy metal and organocholorine
pesticides in the soil and water in this region
(Abdel-Haleem et al. 2001; Dekov et al. 1997;
Reinhardt et al. 2001; Siegel et al. 1994). High
concentrations of heavy metals, including cad-
mium, are among the pollutants in the water.
Plants and fish grown in this water are also
contaminated with heavy metals (Abdel-
Sabour 2001; Abou-Arab and Abou Donia
2000), which can in turn accumulate in
humans and animals that feed on these conta-
minated foods (Osfor et al. 1998). The serum
cadmium levels of residents of Dakahlia
Province are almost 10-fold higher than those
of residents from cadmium-polluted areas in
Cairo and 32 times higher than reference levels
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The northeast Nile Delta region exhibits a high incidence of early-onset pancreatic cancer. It is well
documented that this region has one of the highest levels of pollution in Egypt. Epidemiologic
studies have suggested that cadmium, a prevalent pollutant in the northeast Nile Delta region, plays
a role in the development of pancreatic cancer. 
OBJECTIVE: We aimed to assess serum cadmium levels as markers of exposure in pancreatic cancer
patients and noncancer comparison subjects from the same region in Egypt. 
DESIGN AND PARTICIPANTS: We assessed serum cadmium levels of 31 newly diagnosed pancreatic
cancer patients and 52 hospital comparison subjects from Mansoura, Egypt. 
EVALUATION/MEASUREMENTS: Serum cadmium levels were measured using a novel immunoassay
procedure. 
RESULTS: We found a signiﬁcant difference between the mean serum cadmium levels in patients
versus comparison subjects (mean ± SD, 11.1 ± 7.7 ng/mL vs. 7.1 ± 5.0 ng/mL, respectively; p =
0.012) but not in age, sex, residence, occupation, or smoking status. The odds ratio (OR) for pan-
creatic cancer risk was signiﬁcant for serum cadmium level [OR = 1.12; 95% conﬁdence interval
(CI), 1.04–1.23; p = 0.0089] and farming (OR = 3.25; 95% CI, 1.03–11.64; p = 0.0475) but not
for age, sex, residence, or smoking status. 
CONCLUSIONS: The results from this pilot study suggest that pancreatic cancer in the East Nile
Delta region is signiﬁcantly associated with high levels of serum cadmium and farming. 
RELEVANCE TO CLINICAL PRACTICE/PUBLIC HEALTH: Future studies should further investigate the
etiologic relationship between cadmium exposure and pancreatic carcinogenesis in cadmium-exposed
populations. 
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(Hossny et al. 2001; Osfor et al. 1998;
Soliman et al. 2002). Cadmium is a known
human carcinogen (Boffetta 1993) and has
recently been implicated as a cause of pancre-
atic cancer (Schwartz and Reis 2000). Two
main risk factors for pancreatic cancer, age and
cigarette smoking, are also associated with cad-
mium exposure. Cadmium accumulates in the
body over time because there are no specific
mechanisms for its removal. The half-life of
this metal in the body ranges from 10 to
30 years, with an average of 15 years (Jin et al.
1998). In addition, cigarette smoking is a sig-
niﬁcant source of cadmium. One cigarette con-
tains 1–2 µg cadmium (Goyer 1996), and
inhaled cadmium is absorbed much more efﬁ-
ciently than is ingested cadmium (Friberg
1984). Measurement of cadmium in the pan-
creas of autopsy patients showed signiﬁcantly
higher levels in smokers than in nonsmokers
(Elinder et al. 1976). Urinary cadmium levels,
commonly used as an indication of life-long
exposure, are also signiﬁcantly higher in smok-
ers versus nonsmokers (Schwartz et al. 2003).
In this study, we assessed serum cadmium
levels of newly diagnosed histologically con-
ﬁrmed pancreatic cancer patients with hospi-
tal comparison subjects from the same region
in Egypt, using a novel immunoassay proce-
dure. We have also examined the contribu-
tions of age, residence, smoking status, and
profession to overall risk for pancreatic can-
cer. Although the sample size in this study is
small, it is our hope that these initial data will
act as a springboard for larger, more in-depth
studies that will analyze the relationship
between cadmium and pancreatic cancer in a
more detailed fashion.
Materials and Methods
Materials. The 2A81G5 monoclonal antibody,
which recognizes Cd(II)–EDTA complexes,
was prepared from a hybridoma generated in
the Blake laboratory (Blake et al. 1996). A
Cd(II)–EDTA–horseradish peroxidase (HRP)
conjugate was prepared as described by
Darwish and Blake (2002, 2001). We pur-
chased a pooled human serum sample from
Intergen (Milford, MA, USA); this serum sam-
ple was analyzed by graphite-furnace atomic
absorption spectroscopy (AAS) and shown to
be free of endogenous cadmium (data not
shown). ELISA high-binding 96-well plates
were a product of Corning-Costar (Cambridge,
MA, USA). We obtained AAS standard cad-
mium (1,000 mg/L in 2% nitric acid) from
Perkin-Elmer (Norwalk, CT, USA).
Patient selection. Between September 2001
and February 2002, 31 newly diagnosed
patients with adenocarcinoma of the pancreas
from the Gastrointestinal Surgery Center of
Mansoura University, Dakahlia Province in
Egypt were recruited to participate in this
study. Pancreatic cancer was confirmed by
reviewing the histopathologic slides of all
patients both at Mansoura University and at
M.D. Anderson Cancer Center. No patients
with chronic pancreatitis were included in this
study. Histopathologic examination of the tis-
sues of the pancreatic cancer patients included
in the study revealed no signs of chronic pan-
creatitis. All patients were Egyptian citizens,
permanent residents of Dakahlia Province, and
recruited before receiving chemotherapy or
radiotherapy. There were no restrictions based
on age, sex, or tumor stage. In addition,
52 comparison subjects were recruited from
the ear-nose-throat and ophthalmology depart-
ments at Mansoura University General
Hospital on the same medical campus of
Mansoura University. The comparison subjects
were chosen by systematic random sampling
from inpatients admitted for surgeries related
to nonchronic illnesses. After the nature of the
study had been fully explained, informed oral
and/or written consent was obtained from each
person in the study.We used an interviewer-
administered questionnaire, which included
questions about lifetime occupational, residen-
tial, and smoking histories. Information was
also collected about family history of pancre-
atic cancer.
Sample collection. For each patient and
comparison subject, 10 mL of blood was col-
lected into a sterile nonheparinized Vacutainer
tube. The sample was allowed to clot for
5–10 min and then centrifuged for 10 min at
13,000 rpm. At least 2 mL of clear serum from
each sample was transferred to glass tubes,
which were labeled with patient name and
identiﬁcation number, clinic name, and collec-
tion time and date. Specimens were frozen at
–20°C until they were transferred (within
3 weeks) to M.D. Anderson Cancer Center.
Samples were hand-carried in dry ice during
transport from Egypt to Houston to New
Orleans, Louisiana, where they were stored at
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Figure 1. Modiﬁed one-step assay for Cd(II) in human serum. (A) Cadmium was ﬁrst displaced from metallo-
thionein and other proteins under acidic conditions. (B) An EDTA-containing buffer was added to the serum
to form Cd(II)–EDTA complexes, which are recognized by the 2A81G5 antibody. (C) Microwell plates were
coated and blocked as described in “Materials and Methods.” A serum sample was mixed 1:1 with enzyme-
labeled Cd(II)–EDTA and subsequently added to the coated wells. The enzyme-labeled Cd(II)–EDTA com-
petes with the Cd(II)–EDTA complexes from the serum sample for immobilized antibody binding sites. (D)
Peroxidase substrate was added to the wells and absorbance was read at 450–650 nm.
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e–80°C. The study was approved by the human
subject committees of the Universities of
Texas, Tulane, and Michigan in the United
States and Mansoura University in Egypt. 
Modiﬁcation of the one-step immunoassay
for cadmium in serum. The method described
by Soliman et al. (2002) required relatively high
quantities of the anti-cadmium monoclonal
antibody, 2A81G5. Therefore, we modiﬁed the
original method by using a goat anti-mouse
antibody to capture and concentrate the
2A81G5 antibody on the microwell plate, as
shown in Figure 1. Preliminary experiments
demonstrated that when goat anti-mouse IgG,
coated at a concentration of 2.0 µg/mL, was
used to capture mouse monoclonal antibody,
5-fold less 2A81G5 was required for the subse-
quent cadmium assay (data not shown).
Pooled human serum versus pooled
Egyptian comparison serum. We calculated
standard curves in two separate sample matrices
using the modiﬁed one-step immunoassay for
cadmium. We compared a pooled human
serum sample from Intergen Co. (Norcross,
GA, USA) with a mixture of all the comparison
samples from Egypt in a competition assay.
Twenty-five microliters of each of the
52 Egyptian comparison samples were com-
bined together and mixed well. Various con-
centrations of atomic absorption grade
cadmium were spiked into the Egyptian pooled
serum as well as Intergen’s pooled serum
(Norcross, GA, USA). We then performed an
immunoassay and compared inhibition curves. 
Determination of cadmium in human
serum samples. We diluted goat anti-mouse
IgG1 (heavy chain speciﬁc; Jackson Immuno-
Research Laboratories, West Grove, PA, USA)
into HEPES-buffered saline (HBS; 137 mM
NaCl, 3 mM KCl, and 10 mM HEPES,
pH 7.4) to a concentration of 2 µg/mL. The
diluted antibody (50 µL) was introduced
to each well of a 96-well high-binding micro-
well plate and incubated for 2 hr at 37°C.
The plates were washed three times with
phosphate-buffered saline containing 0.05%
Tween-20. The wells were blocked with 3%
bovine serum albumin in HBS at 37°C for
1 hr, followed by a wash step. The anti-
Cd(II)–EDTA antibody, 2A81G5, was diluted
to 0.5 µg/mL in HBS. A 50 µL aliquot of the
diluted antibody was added to each well and
incubated at room temperature for 1 hr, fol-
lowed by a wash step.
Egyptian serum samples were thawed at
room temperature and mixed well. A 75 µL
aliquot of serum was added to 75 µL of 5%
HNO3 and mixed well. The mixture was incu-
bated at room temperature for 5 min and then
spun at 15,000 rpm for 5 min. Acidiﬁcation of
the sample allows the release of cadmium from
metallothionein and other protein ligands. A
90 µL aliquot of the supernatant was removed
and conditioned with 10 µL of a 10X concen-
trated buffer (1.37 M NaCl, 30 mM KCl,
50 mM EDTA, 100 mM HEPES). The pres-
ence of EDTA allows the formation of
Cd(II)–EDTA complexes. The sample was
neutralized with 10 M KOH. Neutralized
serum was added to an equal volume of
0.1 µg/mL Cd(II)–EDTA–HRP and mixed
well. The mixture (50 µL/well) was added to
three separate wells. After 1 hr incubation at
room temperature, the plate was washed.
3,3´,5,5´-Tetramethylbenzidine peroxidase
substrate (50 µL/well; Kirkegaard-Perry
Laboratories, Gaithersburg, MD, USA) was
added to each well, and color formation was
stopped after 10 min with an equal volume of
1 N HCl. The absorbance of each well was
measured in a dual-wavelength mode
(450–650 nm) using a Vmax Kinetic Microplate
Reader (Molecular Devices Corporation,
Sunnyvale, CA, USA). For preparation of a
standard curve, pooled human serum from
Intergen was spiked with various concentrations
of atomic-absorption–grade cadmium standard
and treated in a manner identical to that used
for the serum samples noted above.
Data analysis for the immunoassay. We
calculated standard curves on each immunoas-
say plate in replicates of four. We determined
the mean value and SD of the absorbance pro-
vided by each cadmium concentration. These
mean absorbance values (y) were plotted on a
curve versus the cadmium concentrations (x)
and used to ﬁt the equation y = a0 – (a1 × x)/(a2
+ x), where y is the experimental absorbance, x
is cadmium concentration in the standard or
sample, a0 is the absorbance in the absence of
cadmium, a1 is the difference between the
absorbance in the absence of cadmium and at a
saturating concentration of cadmium, and a2 is
the Cd(II) concentration that produces a 50%
inhibition of signal (IC50). To account for the
variability in the data, conﬁdence bounds for
each standard Cd(II) concentration were com-
puted. The upper and lower curves were fit
from the mean values ± 2 SD, respectively.
The limit of detection (LOD) was determined
with the use of the standard curves. The
absorbance value for zero cadmium (y-inter-
cept) for the lower curve (mean – 2 SD) was
determined and then applied to the upper
curve (mean + 2 SD) to find the cadmium
concentration designated as the LOD. A visual
depiction of how the LOD was determined is
provided in Figure 2.
Each Egyptian serum sample was analyzed
in triplicate in a particular assay. The mean
absorbance value and SD were determined for
each sample. We used SDs to help eliminate
nonprecise values. Mean absorbance values for
each serum sample were applied to the mean
standard curve performed on the same plate to
determine the cadmium concentration for that
sample. When the sample was analyzed multi-
ple times, the cadmium concentrations were
averaged. Each original serum sample was
diluted by a factor of 4.57 during the
immunoassay procedure. To obtain the actual
cadmium concentration of the serum samples,
the assay cadmium concentration was multi-
plied by this number.
Statistical methods. For those samples that
fell below the LOD (18 of 52), we used the
method described by Helsel (1990) to assign a
value for the cadmium concentration. In this
method, one assumes that the actual cadmium
concentration in these samples is described by
a Gaussian distribution whose lower bound is
zero and whose upper bound is the LOD of
the immunoassay. The median cadmium con-
centration in these samples would be 50% of
the LOD, and this value was therefore
assigned to each nondetect sample. This is a
conservative method of handling immunoas-
say data; the actual differences between the
cases and the comparisons might be even
greater than reported herein. The logarithm of
serum cadmium level was used as the continu-
ous exposure because the distribution of serum
cadmium level was skewed. We used the
Student’s t-test to test the differences among
means of the logarithms of serum cadmium
level. Because both transformed and untrans-
formed analytical methods yielded comparable
conclusions, we present the analysis based on
the untransformed data for better comparison
with other studies.
We also aimed to ﬁnd a subset of predic-
tors for pancreatic cancer disease status. The
main response variable was disease status and
potential predictors included age, sex, serum
cadmium level, smoking, and farming. We
analyzed the longest occupation reported by
study subjects as farming and nonfarming.
Farming jobs were deﬁned as being a farmer
or a housewife who lived in a rural area.
Nonfarming occupations included adminis-
trators, barbers, businessmen, teachers, stu-
dents, and women who lived in urban areas
but reported their job title as “housewife.”
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Figure 2. Typical standard curve using the one-step
assay for Cd(II) in pooled human serum. See
“Materials and Methods” for details. Data shown
were the means of four replicates with a best-ﬁt line
(solid). Dashed lines on either side of the main curve
represent the best-ﬁt line of the mean values ± 2 SD. 
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LODNonfarming also included industrial workers,
such as painters and welders. We did not
include residence in the final model because
of its high correlation with occupation.
Residence alone was not signiﬁcant in a logis-
tic regression model that did not include
occupation. In this analysis, a study subject
was considered a smoker if he or she reported
ever smoking 100 cigarettes.
Multiple logistic regression models were ﬁt-
ted based on the variables chosen from the uni-
variate analysis. The logistic regression models
were designed to estimate the probability of
having pancreatic cancer, whereas incorporating
the covariates of age, sex, serum cadmium lev-
els, occupation, and smoking. p-Values < 0.05
are reported as signiﬁcant. There is no collinear-
ity among the predictors. The Hosmer and
Lemeshow goodness-of-ﬁt test was used to test
the model ﬁtting. All the statistical tests were
two sided. Data were analyzed using the
Statistical Analysis System package (version 8.2;
SAS Institute Inc., Cary, NC, USA).
Results
One-step immunoassay for cadmium. In this
study we used a previously published
immunoassay procedure to quantify cadmium
in serum samples. The assay was selective for
cadmium; other metal ions, including man-
ganese, cobalt, copper, zinc, magnesium, mer-
cury, calcium, nickel, iron, and lead, did not
signiﬁcantly interfere with the assay even when
tested at concentrations considerably higher
than those present in human serum (Darwish
and Blake 2002). The original one-step
immunoassay for cadmium designed by
Darwish and Blake (2002) required 125 ng of
2A81G5 antibody to be coated in each micro-
well. With the large number of Egyptian
serum samples to be assayed, an unacceptable
quantity of antibody would have been
required for these experiments. We therefore
developed a modification of the original
method that reduced the amount of 2A81G5
necessary for the capture of the Cd(II)–EDTA
complexes by 5-fold. An overall schematic of
the modified one-step assay is shown in
Figure 1. In human serum, cadmium usually
exists as a complex with metallothionein and
other proteins. In order to determine the total
level of cadmium in a serum sample, cadmium
must be extracted from these proteins, a
process most effectively achieved by acidiﬁca-
tion of the sample. Addition of a conditioning
buffer containing EDTA allowed the forma-
tion of Cd(II)–EDTA complexes. This unla-
beled Cd(II)–EDTA competed with a known
concentration of enzyme-labeled Cd(II)–
EDTA to bind to the 2A81G5 antibody
immobilized on the microwell plate. After a
wash step to remove unbound Cd(II)–EDTA
and Cd(II)–EDTA–HRP, a chromogenic per-
oxidase substrate was added and HRP activity
was detected. A standard curve was prepared
by adding varying concentrations of atomic
absorption grade cadmium to a pooled human
serum sample that was treated in an identical
manner as the patient samples. This standard
curve was then used to determine the concen-
tration of cadmium in each sample based on
the observed spectrophotometric absorbance.
Pooled human serum used preparation of
the standard curve. In previous studies
(Darwish and Blake 2002), a pooled human
serum sample obtained from Intergen was used
as the sample medium for preparing the
standard curves on each of the immunoassay
plates. In the present study, however, we were
concerned that this pooled serum sample, from
U.S. donors, might not be an appropriate
medium for analysis of Egyptian donors. A
large pooled serum sample from Egyptian
donors was not available, so we prepared a
small pooled sample by combining an equal
volume (25 µL) of all the Egyptian noncancer
comparison samples available from this study
(a total of 52). The two pooled serum samples
(from Intergen and the Egyptian comparisons)
were spiked with various concentrations of
cadmium and the subsequent inhibition curves
were compared. As shown in Figure 3, the two
curves were nearly identical. IC50 values were
very similar, 16.74 ng/mL and 17.44 ng/mL
for Intergen and Egyptian samples, respec-
tively. These data indicate that the Egyptian
samples did not contain any endogenous com-
ponents that might affect immunoassay perfor-
mance and that the pooled human serum from
Intergen was an appropriate medium for all
subsequent standard curves.
Standard curve and determination of LODs
in the immunoassay. A typical standard curve,
obtained by adding known concentrations of
cadmium and EDTA to a pooled human serum
sample, is shown in Figure 2. As the concentra-
tion of unlabeled cadmium increased, less of the
enzyme-labeled Cd(II)–EDTA was able to bind
to the 2A81G5 immobilized in the microwell;
absorbance in the assay decreased as the unla-
beled cadmium concentration increased. Four
replicates of each standard concentration were
Kriegel et al.
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Figure 3. Pooled human serum versus pooled
Egyptian comparison serum. Binding curves were
calculated with cadmium spiked into the pooled
human serum from Intergen or into a sample of
pooled Egyptian comparison serum. IC50 values
were very similar, 16.74 ng/mL and 17.44 ng/mL for
Intergen and Egyptian samples, respectively.
Values reported are mean ± SD (n ≥ 6).
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Table 1. Characteristics of the study population [n (%)].
Characteristic Case (n = 31) Comparison (n = 52) p-Value
Age (years)
< 60 21 (67.7) 41 (78.8) 0.3023
≥ 60 10 (32.3) 11 (21.2)
Sex
Male 19 (61.3) 30 (57.7)
Female 12 (38.7) 22 (42.3) 0.8198
Residence
Rural 15 (48.4) 15 (28.8) 0.0989
Urban 16 (51.6) 37 (71.2)
Smoking
Yes 11 (35.5) 21 (40.4)
No 20 (64.5) 31 (59.6) 0.8161
Occupation
Farmer 7 (22.6) 3 (5.8) 0.0805
Housewife 10 (32.3) 19 (36.5)
Industrial 8 (25.8) 11 (21.2)
Professional 6 (19.4) 19 (36.5)
Farming-related occupation
Yes 11 (35.5) 8 (15.4)
No 20 (64.5) 44 (84.6) 0.0570
Serum cadmium level (ng/mL)
Total
Mean ± SD 11.1 ± 7.7 7.1 ± 5.0 0.0120
Median (range) 11.0 (27.9) 5.7 (24.2)
Smokers
Mean ± SD 11.8 ± 9.3 7.1 ± 4.7 0.1386
Median (range) 13.7 (27.0) 6.4 (16.5)
Nonsmokers
Mean ± SD 10.7 ± 6.9 7.1 ± 5.3 0.0380
Median (range) 11.0 (27.0) 5.5 (24.2)
p-Values for quantitative variables were calculated using Student’s t-test; p-values for proportions and qualitative vari-
ables were calculated using the chi-square test. analyzed. The average values of each four stan-
dard replicates were plotted on the graph and
ﬁtted using the equation described in “Materials
and Methods” (Figure 2). Variability (2 × SD)
was determined and graphed as described in
“Materials and Methods” (Figure 2). These
upper and lower limit curves were used to deter-
mine the LOD of the immunoassay, as shown
in Figure 2. The LODs were determined for
each standard curve and ranged between 0.4
and 1.0 ng/mL cadmium for the pancreatic can-
cer patients and between 0.3 and 1.0 ng/mL
cadmium for the comparison subjects. These
ranges show the consistency of standard curves
performed from day to day and the high sensi-
tivity of the assay. Each sample was assayed at
least one time in triplicate. Many of the samples
were assayed on multiple days, also in triplicate.
The average absorbance value was detected and
then applied to the mean standard curve like the
one shown in Figure 2 to obtain a serum cad-
mium concentration.
Characteristics of the study population.
There were no signiﬁcant differences between
the pancreatic cancer patients and the compari-
son subjects in terms of age, sex, residence,
smoking status, or occupation, as shown in
Table 1. Across the study population, age
ranged from 21 to 75 years, with a median age
of 52 in the cases and 49 in the comparison
subjects. There were slightly more males than
females in each group. Most study subjects
(52% and 71% in cases and comparison sub-
jects, respectively) were urban dwellers, and
almost two-thirds were nonsmokers. Less than
half of the cases had professional backgrounds,
compared with two-thirds of the comparison
subjects. There was, however, a signiﬁcant dif-
ference in mean serum cadmium levels between
the cases and comparisons (p = 0.012). In
patients with pancreatic cancer, the mean cad-
mium level was 11.1 ± 7.7 ng/mL, whereas in
the comparisons the mean ± SD was 7.1 ±
5.0 ng/mL. Although pancreatic cancer patients
who reported histories of smoking showed
higher but not signiﬁcant differences in serum
cadmium levels than those of comparison sub-
jects who reported histories of smoking (11.8 ±
9.3 ng/mL and 7.1 ± 4.7 ng/mL, p = 0.14, in
patients and comparison subjects, respectively),
there were statistically higher serum cadmium
levels in nonsmoker patients than in non-
smoker comparison subjects (10.7 ± 6.9 ng/mL
and 7.1 ± 5.3 ng/mL, p = 0.038, in patients and
comparisons, respectively. 
A comparison of the different ranges of
cadmium levels determined in the serum sam-
ples of the case and comparison populations is
shown in Figure 4. Most comparison subjects
exhibited serum cadmium levels between the
LOD and < 10 ng/mL, with only one
> 20 ng/mL Cd(II). The pancreatic cancer
patients showed an overall trend toward
higher serum cadmium concentrations. Most
cases demonstrated serum cadmium levels
between 10 and 20 ng/mL, and 4 of 31 exhib-
ited cadmium levels > 20 ng/mL.
Variation in cadmium levels in the study
population. Within the study population as a
whole, there were no signiﬁcant differences in
serum cadmium levels as a function of sex,
residence (rural or urban), or smoking status,
as shown in Table 2. There was a trend
toward signiﬁcance on the basis of occupation
(p = 0.0827) with farmers showing the high-
est levels (mean ± SD, 13.34 ± 8.29 ng/mL),
followed by industrial workers (8.68 ±
5.46 ng/mL) and professionals (7.84 ±
6.14 ng/mL). 
Risk factors for pancreatic cancer. The
association between pancreatic cancer risk and
subject age, residence (urban or rural), smok-
ing status, and occupation (farming or non-
farming) is indicated by the odds ratios (ORs)
shown in Table 3. Both serum cadmium levels
and farming were independently associated
with increased risk of pancreatic cancer. The
OR for serum cadmium levels was 1.12 [95%
confidence interval (CI), 1.04–1.23; p =
0.0089]. Farming was associated with
increased risk for pancreatic cancer OR = 3.25
(95% CI, 1.03–11.64) (Table 3).
Discussion
In this pilot study, we tested the hypothesis that
pancreatic cancer patients in this Egyptian pop-
ulation were exposed to higher levels of cad-
mium than were noncancer subjects. Serum
cadmium levels were used as a marker for cad-
mium exposure. It is difﬁcult to ﬁnd a perfect
dose estimator for cadmium. Urinary cadmium
levels are often used; however, studies with ani-
mals and humans have shown that renal dam-
age may lead to higher than normal cadmium
excretion (Friberg et al. 1985; Nordberg and
Piscator 1972). Jarup et al. (1997) have shown
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Figure 4. Distribution of samples and serum Cd(II)
concentrations in comparison subjects versus pan-
creatic cancer patients. The values reported are the
percentage of the total samples for that population. 
60
50
40
30
20
10
0
P
e
r
c
e
n
t
 
t
o
t
a
l
 
s
a
m
p
l
e
s
< LOD LOD– < 10 ng/mL 10–20 ng/mL > 20 ng/mL
Comparison
Case
Table 2. Serum cadmium concentration (ng/mL) in the combined patients and comparison sample.
No. Mean ± SD Median (range) p-Value
Sex
Male 49 9.21 ± 7.09 7.77 (27.88)
Female 34 7.72 ± 5.21 6.40 (19.19) 0.2966
Residence
Rural 30 8.52 ± 6.31 7.31 (20.11) 0.9281
Urban 53 8.65 ± 6.51 6.86 (27.42)
Smoking
Yes 32 8.75 ± 6.86 7.08 (27.42)
No 51 8.5 ± 6.16 6.86 (26.96) 0.8634
Occupation
Farmer 10 13.34 ± 8.29 11.88 (1.83–28.79) 0.0827
Housewife 29 7.56 ± 6.05 5.94 (0.91–27.88)
Industrial 19 8.68 ± 5.46 7.77 (0.91–16.45)
Professional 25 7.84 ± 6.14 5.03 (1.37–25.14)
p-Values for quantitative variables were calculated using Student’s t-test; p-values for proportions and qualitative vari-
ables were calculated using the chi-square test. 
Table 3. ORs of risk factors for pancreatic cancer.
Case Comparison OR
(n = 31) (n = 52) (95% CI) p-Value
Serum cadmium level (ng/mL, mean ± SD) 11.1 ± 7.7 7.1 ± 5.0 1.12 (1.04–1.23) 0.0089
Age [years, n (%)]
< 60 21 (67.7) 41 (78.8) 1 0.1677
≥ 60 10 (32.3) 11 (21.2) 2.25 (0.71–7.26)
Sex [n (%)]
Male 19 (61.3) 30 (57.7) 2.06 (0.51–8.61) 0.311
Female 12 (38.7) 22 (42.3) 1
Smoking [n (%)]
Yes 11 (35.5) 21 (40.4) 0.54 (0.13–2.19) 0.3859
No 20 (64.5) 31 (59.6) 1
Farming-related occupation [n (%)]
Yes 11 (35.5) 8 (15.4) 3.25 (1.03–11.64) 0.0475
No 20 (64.5) 44 (84.6) 1
ORs were calculated using logistic regression analysis. p-Values for quantitative variables were calculated using
Student’s t-test; p-values for proportions and qualitative variables were calculated using the chi-square test. that blood cadmium can provide a better dose
estimate than urinary cadmium concentra-
tions, especially when tubular proteinuria is
present. During high cadmium exposures, the
cadmium in the blood increases relatively
rapidly until, after some months, it reaches a
concentration that corresponds to the intensity
of exposure. If the exposure stops, the blood
cadmium decreases with an initial half-time of
2–3 months (Elinder et al 1994; Jarup et al.
1983). Cadmium accumulated in the body,
however, will continue to inﬂuence blood lev-
els. Even after exposure ceases, the concentra-
tion in the blood never returns to preexposure
levels. Thus blood cadmium has been proposed
as one of the more accurate estimators of accu-
mulated body burden (Alfven et al. 2002).
Only about 10% of whole-blood cadmium is
circulating in serum, but serum levels appear to
correlate with blood levels (Lauwerys et al.
1994). The use of serum rather than whole
blood in this study allowed us much greater
ﬂexibility in collecting, storing, and transport-
ing patient samples.
In the patient population studied here,
serum cadmium levels and farming were strong
independent risk factors for pancreatic cancer,
whereas age, sex, smoking, and residence were
not. The highly signiﬁcant association of pan-
creatic cancer with serum cadmium level is also
consistent with other epidemiologic evidence.
The strongest suspicion of an association
between cadmium exposure and pancreatic
cancer has been reported in Louisiana (Blot
et al. 1978; Lemus et al. 1996; Tchounwou
et al. 1996). Industrial activity along the
Mississippi River has led to an accumulation of
contaminants in southern Louisiana (Mielke
et al. 2000). Seafood and rice are popular food
items in the local diet. Both rice and ﬁsh har-
vested from cadmium-polluted areas may con-
tain high levels of cadmium (Ikeda 1992;
Modigosky et al. 1991). A case–control study
in Louisiana showed a signiﬁcantly increased
risk for pancreatic cancer associated with rice
consumption among Cajuns, with a dose–
response relationship (Falk et al. 1988).
Louisiana residents are also exposed to cad-
mium by inhalation. Lemus et al. (1996) have
shown that 64 of 315 samples (20.3%) of
indoor and outdoor air from 53 households in
Louisiana exceeded the U.S. Environmental
Protection Agency’s permissible levels for cad-
mium (Lemus et al. 1996). It is interesting to
note the association between pancreatic cancer
risk and farming in this study (OR = 3.25, p =
0.0475).
Although smoking has been identiﬁed as a
strong risk factor for pancreatic cancer in previ-
ous studies (Doll et al. 1994; Howe et al.
1991), it was not significant in this study.
There are at least two possible explanations for
this ﬁnding. First, most subjects (approximately
two-thirds) in both the case and comparison
groups were nonsmokers. Second, cadmium is
a by-product of cigarette smoke, and adjusting
for serum cadmium levels in this study may
have controlled for the effect of smoking. There
was also no signiﬁcant association between risk
of pancreatic cancer and residence. Although
rural residents might be expected to show
increased risk because of exposure to pesticides
and fertilizers (Anderson et al. 1996; Fontham
and Correa 1989), exposure of urban industrial
workers employed in manufacturing (Norell
et al. 1986; Sheffet et al. 1982), metalworking
(Maruchi et al. 1979; Rotimi et al. 1993;
Silverstein et al. 1988), and soldering (Ji et al.
1999) may be equally signiﬁcant. There may
also be other important differences in cadmium
exposure (e.g., diet and air quality) that distin-
guish urban from rural populations. Reports
from urban areas in Egypt have shown high lev-
els of cadmium in organ meats that are fre-
quently consumed by the local population
(Abou-Arab and Abou Donia 2000). A recent
study on markers of environmental pollution in
Egypt has also shown signiﬁcantly higher levels
of oxidative damage in urban populations,
compared with rural populations (Soliman
et al. 2004). The higher risk of pancreatic can-
cer associated with farming in this study may
reﬂect the intense exposure to cadmium and
other farming-related occupations in this
population. Thus, two major risk factors may
have overshadowed the relationship between
smoking and cadmium levels in this study.
The ﬁrst was the exceptionally high levels of
environmental pollution in our study region.
The second included the high dietary intake
of rice and fish grown in polluted soils and
water of the study region. The National Food
Consumption Study in Egypt has shown that
residents of our study region of Dakahlia
Province consume more ﬁsh and rice than does
any other group in Egypt (Galal and Khorshid
1995). Unfortunately, neither detailed envi-
ronmental exposures nor dietary intake was
measured in the present study.
Studies with rodents showed the ability of
the pancreas to accumulate high concentra-
tions of cadmium. Mice injected with 4 mg/kg
CdCl2 expressed a 2.5-fold increase in DNA
synthesis in the pancreas, which Andrews et al.
(1990) and Hellman (1986) interpreted as a
sign of increased metallothionein synthesis.
Rats injected with 4 and 8 mg/kg cadmium
demonstrated 9.8- and 17.9-fold increases,
respectively, in pancreatic metallothionein lev-
els (Wormser and Calp 1988). Cadmium
interferes with the use of essential metals such
as calcium, zinc, selenium, and iron.
Deﬁciencies of these essential metals, in con-
junction with protein and vitamin deﬁciencies,
exaggerate cadmium toxicity by increasing
absorption through the gut and enhancing
retention in different organs (Waalkes 1986).
Studies on adult Wistar rats showed that zinc
deﬁciency markedly increases cadmium accu-
mulation in various organs (Waalkes 1986).
Studies from our research region (Galal and
Khorshid 1995) showed that 46% of women
have a calcium intake < 50% of the required
daily allowances (RDA); the consumption of
B12, a marker of protein intake, is also < 50%
of the RDA in 33% of women in the region.
Nutritional deficiencies in our study region
may be a major factor in cadmium accumula-
tion in body organs of the local population.
Cadmium is a potent carcinogen in
rodents. Injecting rats with CdCl2 resulted in
a signiﬁcant increase (from 2.2% to 8.5%) in
the incidence of pancreatic islet cell tumors
(Poirier et al. 1983). In experiments designed
to determine the carcinogenic effects of
repeated exposure to CdCl2, Fischer and
Wistar rats showed a very high incidence of
dose-related pancreatic metaplasia, as reﬂected
by pancreatic hepatocyte formation (Konishi
et al. 1990). These pancreatic hepatocytes are
thought to arise from the ductal and intersti-
tial cells of the pancreas, which resemble oval
cells of the liver (Rao et al. 1986). Cadmium
may activate oncogenes such as c-myc, mdm2,
and cellular tumor antigen p53; inhibit tumor
suppressor genes such as wild-type p53 and
p27; and consequently promote the prolifera-
tion of initiated cells (Fang et al. 2002).
The present study has several important
strengths. The Dakahlia region has docu-
mented high levels of pollution and is therefore
a unique setting for studying environmental
risk factors and cancer occurrence. The stabil-
ity of population without migration in
Dakahliam maximizes the chances of life-long
environmental exposure (Aly and Shields
1996). The high incidence of young pancreatic
cancer patients (younger than 50 years of age)
provides a unique model system for studying
the effect of early environmental exposures on
pancreatic carcinogenesis (Soliman et al.
2002). Finally, the wide range of occupational
and lifestyle factors in this region provide help
to investigate the occupational and epidemio-
logic risk factors associated with pancreatic
cancer. The relatively small sample size of this
rare cancer may limit the generalization of
results.
In summary, this pilot study has shown a
statistically significant association between
pancreatic cancer and serum cadmium levels
and farming. Future studies should expand on
this pilot investigation by studying a larger
number of pancreatic cancer patients and by
collecting extensive information on the life-
time occupational, residential, and environ-
mental exposures and dietary influences in
order to clarify the role of cadmium in pancre-
atic cancer etiology in this population. Several
molecular mechanisms have been identiﬁed by
which cadmium may inﬂuence pancreatic cells
(Chai et al. 1999; Merali and Singhal 1976;
Kriegel et al.
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Shimoda et al 2001; Waalkes et al. 1992), and
a better understanding of these processes is
under study in our laboratories. It will also be
important to examine genetic susceptibility
and markers of genetic damage caused by
environmental exposures to clarify the role of
such exposures in pancreatic carcinogenesis.
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